Sleep Number's Q3 2025 results fell short of expectations, reflecting ongoing challenges in sales performance amidst a major business turnaround effort. However, the company has secured financial flexibility through a new bank agreement and implemented substantial cost reduction initiatives, positioning itself for potential recovery in 2026.

• Q3 operating results were disappointing, with sales impacted by aggressive competition and reduced marketing spend.
• Achieved $115 million in cost reductions in 2025, exceeding the $130 million target, despite reduced sales affecting gross margins.
• Secured an amendment and extension of the bank agreement through 2027, enhancing financial flexibility for future growth initiatives.
• Plans to optimize marketing strategies and explore new distribution channels to attract a broader customer base while maintaining operational efficiency.
• Confidence in stabilizing top-line performance and improving adjusted EBITDA and free cash flow by 2026 due to cost management and product evolution initiatives.